$5.5 billion bond ($7.8 billion total cost) to extend the California Institute for Regenerative Medicine’s stem-cell research. Despite the fact that it’s a lot of money to spend at a time when a lot of Californians are out of work, the potential benefits of developing treatments for everything from Parkinson’s to blindness is too important to let the program shut down.